3SBio

Pharma

Pfizer, Alzheimer's blood test, Samsung—Fierce Pharma Asia

Pfizer joined the PD-1xVEGF bispecific race. The FDA approved its first Alzheimer's blood test. Samsung Biologics plans a biosimilar spinoff. And more.

Angus Liu May 23, 2025 9:00am

Sinopharm, Sinovac, Takeda and more—FiercePharmaAsia

Jun 19, 2020 10:44am

AstraZeneca, Pfizer Japan and more—FiercePharmaAsia

Feb 15, 2019 10:53am

FiercePharmaAsia—China's landmark nod, Samsung, WuXi and more

May 4, 2018 9:56am

FiercePharmaAsia—Eli Lilly, OrbiMed, Takeda

Sep 8, 2017 8:13am

China’s 3SBio JV seeks to buy Canadian CDMO Therapure for $290M

Sep 7, 2017 9:38am